Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-03-24Clinical Trial Update: Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast Cancer [NA]
This clinical trial evaluating fine art photographs and visualization tapes to improve surgical recovery in breast cancer has been terminate…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients
The trial update reports completion of a study evaluating collection of circulating tumor cells from the peripheral blood of patients with m…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer [Phase 2]
Phase 2 trial evaluating a combination of docetaxel, carboplatin, trastuzumab, and lapatinib in early-stage breast cancer completed with res…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluated intermittent Letrozole therapy in postmenopausal women with metastatic breast cancer; the study was terminated with …
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)
This ClinicalTrials.gov update notes the completion of a study evaluating Molecular Breast Imaging (MBI) in patients with suspected ductal c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery [Phase 1]
Phase 1 trial of AVB-620 in women with primary, non-recurrent breast cancer undergoing surgery has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating the combination of lapatinib with radiation therapy in patients with locally recurrent or chemotherapy-refractory l…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer [Phase 2]
Phase 2 trial evaluated first-line capecitabine (Xeloda) with lapatinib (Tykerb) for HER2-positive breast cancer; the study was terminated a…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Detection of Breast Lesions by Automatic Breast US
The update describes a clinical trial evaluating the use of automatic breast ultrasound to detect breast lesions.
-
CLINICAL_TRIALS research · 2017-03-20Clinical Trial Update: Breast Cancer, Sexuality and Black Cohosh [Phase 4]
This is a Phase 4 clinical trial update examining sexuality-related outcomes in individuals with breast cancer treated with Black cohosh.
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Longitudinal
This document provides an update on the completed PICTURE Breast L study, a longitudinal evaluation of patient information for local therapy…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional
A completed cross-sectional clinical trial update from University College London evaluating patient information for local therapy outcome as…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer [Phase 3]
A Phase 3 trial evaluated whether pyridoxine and a topical urea/lactic acid-based cream can prevent hand-foot syndrome in patients treated w…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating the effects of inhibiting platelet function on circulating cancer cells in breast cancer patients. The stu…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer
A completed clinical study investigated cells collected by ductal lavage from women undergoing surgery for ductal carcinoma in situ or other…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment [NA]
Completed clinical trial exploring Healing Touch, quality of life, and immune factors in breast cancer patients undergoing treatment.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer [Phase 2]
This document reports a completed Phase 2 clinical trial evaluating dimethyldiguanide in combination with an aromatase inhibitor for metasta…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Impact of Art Therapy on Fatigue and Quality of Life of Patients Treated With Adjuvant Radiotherapy for Breast Cancer [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating whether art therapy reduces fatigue and improves quality of life for patients undergoing adjuvant radiot…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma [NA]
A completed efficacy study evaluating clinical nutrition for treating lung cancer and breast cancer.
-
FDA approval · 2017-03-13FDA Approved: KISQALI — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved Kisqali (ribociclib) in its original application (NDA 209092) from Novartis Pharmaceuticals Corporation for a breast cancer ind…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating a doxorubicin/cyclophosphamide regimen followed by paclitaxel, trastuzumab, and lapatinib in HER2-positive…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer [Phase 2]
A randomized phase 2 trial evaluating neoadjuvant chemotherapy customized by BRCA1- and HER2-negative breast cancer has completed. The updat…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer [Phase 2]
Phase 2 trial of acolbifene in premenopausal women at high risk for breast cancer completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women [NA]
The clinical trial update notes the completion of a pilot study evaluating docosahexaenoic acid (DHA) in obese menopausal women, with Breast…
-
CLINICAL_TRIALS withdrawal · 2017-03-13Clinical Trial Update: ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer [EARLY_Phase 1]
An EARLY Phase 1 trial of ERB-B4 following histone deacetylase inhibitor treatment in ER-positive, tamoxifen-refractory breast cancer has be…